Vaxart addresses FAQs about reverse stock split proposal
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 12 2025
0mins
Reverse Stock Split Proposal: Vaxart is proposing a reverse stock split to comply with Nasdaq's minimum bid price requirement of $1.00, aiming to avoid delisting and maintain its listing status.
Impact on Shareholders: The reverse stock split will not change the overall value of shareholders' investments or cause dilution; instead, shareholders will own fewer shares at a higher anticipated price per share.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
